Salivary gland cancers are a rare, histologically diverse group of tumors. They range from
indolent to aggressive and can cause significant morbidity and mortality. Surgical resection …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other health care providers on immunotherapy and biomarker testing for head and neck …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary
glands, representing approximately 1% of all head and neck carcinomas and 10% of all …

Salivary gland cancer (SGC) is immensely heterogeneous, both in terms of its physical
manifestation and its aggressiveness. Develo** a novel diagnostic and prognostic …

Simple Summary Patients with adenoid cystic carcinoma (ACC) often experience late distant
metastasis years after definitive therapy, most commonly to the lungs. Currently, there is little …

Surgical resection remains the first line treatment for salivary gland cancer (SGC). In the
case of locally advanced disease, surgery is followed by adjuvant radiotherapy. Surgical …

The use of standardized reporting systems for nongynecologic cytopathology has made
enormous gains in popularity during the past decade, including for thyroid fine-needle …

Opinion statement Adenoid cystic carcinoma (ACC) is a heterogeneous cancer that
commonly develops in the salivary glands. Approximately 40 to 50% of patients with ACC …

Background: The efficacy and safety of human epidermal growth factor receptor 2 (HER2)-
targeted therapy and androgen deprivation therapy (ADT) for locally advanced or recurrent …